Contact
      Please use this form to send email to PR contact of this press release:
      
      Allakos Announces Positive Results with AK002 in Patients with Severe Allergic Conjunctivitis
    
      TO:
      
      
      
      
      
      
      
    
      Please use this form to send email to PR contact of this press release:
      
      Allakos Announces Positive Results with AK002 in Patients with Severe Allergic Conjunctivitis
    
      TO: